LeMaitre Vascular, Inc.
LMAT

$2.07 B
Marketcap
$92.12
Share price
Country
$-0.13
Change (1 day)
$109.58
Year High
$52.88
Year Low

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

marketcap

P/E ratio for LeMaitre Vascular, Inc. (LMAT)

P/E ratio as of 2023: 41.89

According to LeMaitre Vascular, Inc.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 41.89. At the end of 2022 the company had a P/E ratio of 49.01.

P/E ratio history for LeMaitre Vascular, Inc. from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio
2023 41.89
2022 49.01
2021 39.50
2020 38.64
2019 39.72
2018 20.02
2017 35.15
2016 44.23
2015 39.50
2014 32.46
2013 38.32
2012 33.92
2011 42.70
2010 17.59
2009 49.08
2008 -10.85
2007 -32.54
2006 -50.70
2005 929.55
2004 53.11
2003 -213.64
2002 93.59
2001 -73.38